ArticleEuropean radiology2026
Automated psoas muscle segmentation: imaging features and surgical fitness in spinal metastatic lung cancer.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesLung cancer's propensity for spinal metastasis leads to fractures, dysfunction, pain, and reduced quality of life. Spinal interventions are selectively offered to patients deemed fit for surgery. Sarcopenia, assessed by psoas muscle (PM) and whole-abdominal muscle (WAM) measurements, is proposed as a fitness marker, but consensus on thresholds and segmentation tools is lacking. This study aims to validate sarcopenia metrics as imaging biomarkers using both open-source and locally tailored neural networks in the context of bone-metastatic lung cancer and spinal surgery. MATERIALS AND
methodsA retrospective cohort of 63 lung cancer patients (age 64 ± 9, 46% female) with spinal metastases who underwent surgery between 2010 and 2020 was analyzed. PM and lumbar vertebrae segmentation were validated by a musculoskeletal radiologist on CT scans. A local PM segmentation model was trained using nnUNet, and TotalSegmentator (TS) was used for PM and WAM segmentation. Sarcopenia metrics (i.e., PLVI, PM L4 vertebral index (PLVI), psoas muscle index (PMI), skeletal muscle index (SMI), and total muscle area (TMA)) and radiomic features were evaluated. Survival analysis was conducted based on sarcopenia classification using the Wilcoxon log-rank test.
resultsThe locally tailored psoas segmentation model outperformed TS in seven metrics. PMI and PLVI thresholds showed significant survival differences only when measured with the local model (p < 0.05), but not SMI or TMA. Percentile-based classification revealed significant survival differences, especially in local PM metrics (p < 0.001). Of 108 radiomic feature clusters, 38 showed significance with the local models, whereas none did with TS WAM segmentation.
conclusionThe locally tailored model demonstrated superior performance compared to TS. Percentile-based thresholds and PM features were more predictive of survival, underscoring the need for disease-specific cutoffs. Radiomic features warrant further investigation. KEY POINTS: Question Can automated computed tomography assessment of sarcopenia via PM segmentation predict surgical fitness in patients with metastatic lung cancer undergoing spinal surgery? Findings Locally tailored PM segmentations validated known sarcopenia metrics and demonstrated greater significance in predicting patient survival compared to WAM segmentation, using both percentile-based and radiomics features. Clinical relevance The decision to proceed with surgery requires a confident assessment of surgical fitness. As in other surgical contexts, PM sarcopenia assessment through imaging has been validated as a predictor of post-operative survival.
Indexed as
Identifiers
40839132What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.